STOCK TITAN

Tompkins Financial grants Fontaine 630 restricted shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Tompkins Financial Corp (TMP) reported that EVP, General Counsel & CRO Alyssa H. Fontaine received 630 shares of restricted stock on November 9, 2026, at a reported transaction price of $100.76 per share. On the same date, three tax-related dispositions involved 400 shares deemed disposed to the issuer to pay taxes upon vesting. The filing also lists 1,071 shares of common stock held indirectly through a 401K/ESOP.

Insider Fontaine Alyssa H
Role EVP, General Counsel & CRO
Type Security Shares Price Value
Grant/Award Common Stock F1 630 $100.76 $63K
Tax Withholding Common Stock F2 167 $100.76 $17K
Tax Withholding Common Stock F2 90 $100.76 $9K
Tax Withholding Common Stock F2 143 $100.76 $14K
Holding Stock Appreciation Rights (SAR) F3 -- -- --
Holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 10,405.788 shares (Direct); Stock Appreciation Rights (SAR) — 0 rights (Direct); Common Stock — 1,071.2615 shares (Indirect, 401K/ESOP)
Holdings Before and After: Common Stock, 10,175.788 to 10,405.788 shares (Direct)
Footnotes (3)
  1. F1. Restricted stock was granted pursuant to the Tompkins Financial Corporation 2019 Equity Incentive Plan. Restricted stock grants have a five-year vesting schedule with 0% vesting in year one and 25% vesting in years two through five. The grant will expire ten years from the date of the grant.
  2. F2. Deemed disposition of shares to the Issuer to pay for taxes upon vesting of restricted stock.
  3. F3. Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a five-year vesting schedule, with 0% vesting in year one and 25% vesting in years two through five. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.
Restricted stock grant 630 shares Granted November 9, 2026
Reported transaction price $100.76 per share Reported for the restricted stock grant on November 9, 2026
Shares disposed for tax liability 400 shares Three dispositions to the issuer for taxes upon vesting on November 9, 2026
Indirect common-stock holding 1,071 shares Held through a 401K/ESOP
Restricted stock technical
"Restricted stock was granted pursuant to the Tompkins Financial Corporation 2019 Equity Incentive Plan."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
vesting schedule technical
"have a five-year vesting schedule with 0% vesting in year one"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
Stock Appreciation Rights (SARs) technical
"Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did TMP EVP Alyssa H. Fontaine receive in the stock grant?

Tompkins Financial Corp reported a 630-share restricted stock grant to EVP, General Counsel & CRO Alyssa H. Fontaine on November 9, 2026, at a reported price of $100.76 per share. Three tax-related dispositions involved 400 shares deemed disposed to the issuer to pay taxes upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fontaine Alyssa H

(Last)(First)(Middle)
P.O. BOX 460

(Street)
ITHACA NEW YORK 14851

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TOMPKINS FINANCIAL CORP [ TMP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, General Counsel & CRO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/09/2026A630(1)A$100.7610,805.788D
Common Stock11/09/2026F167(2)D$100.7610,638.788D
Common Stock11/09/2026F90(2)D$100.7610,548.788D
Common Stock11/09/2026F143(2)D$100.7610,405.788D
Common Stock1,071.2615I401K/ESOP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Appreciation Rights (SAR)$76.9 (3)11/09/2026Common Stock00D
Explanation of Responses:
1. Restricted stock was granted pursuant to the Tompkins Financial Corporation 2019 Equity Incentive Plan. Restricted stock grants have a five-year vesting schedule with 0% vesting in year one and 25% vesting in years two through five. The grant will expire ten years from the date of the grant.
2. Deemed disposition of shares to the Issuer to pay for taxes upon vesting of restricted stock.
3. Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a five-year vesting schedule, with 0% vesting in year one and 25% vesting in years two through five. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.
Alyssa H. Fontaine11/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading